NCT01911598 - A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2013

Primary Completion Date

June 22, 2017

Study Completion Date

June 22, 2017

Conditions

Head and Neck Cancer

Interventions

DRUG

5-FU

5-FU will be administered as per schedule specified in the respective arm.

DRUG

Carboplatin

Carboplatin will be administered as per schedule specified in the respective arm.

DRUG

Cisplatin

Cisplatin will be administered as per schedule specified in the respective arm.

DRUG

MEHD7945A

MEHD7945A will be administered as per schedule specified in the respective arms.

DRUG

Paclitaxel

Paclitaxel will be administered as per schedule specified in the respective arm.

Trial Locations (6)

Cliniques Universitaires St-Luc, Brussels

UZ Antwerpen, Edegem

UZ Leuven Gasthuisberg, Leuven

University of Chicago; Hematology/Oncology, Chicago

University of Colorado Cancer Center Department of Hematology, Aurora

Massachusetts General Hospital;Hematology/ Oncology, Boston